Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
False
Advertisement
Biopharma
First 20mL Universal Plunger for Large-Volume On-Body Delivery
February 2, 2026
Plunger for 20mL cartridges aims to meet rising demand for on-body delivery of higher dose therapies
1 min read
Resolve M Therapeutics Exits from Stealth
January 29, 2026
Platform designed to engage pro-resolution responses to restore immune homeostasis in inflammatory disorders without broad immuno-suppression
1 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
UK Increase in Advanced Therapy Clinical Trials
January 26, 2026
Number of early-stage trials remains high, according to CGT Catapult data
1 min read
New START for Kumar Muthalagappan
January 20, 2026
Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally
2 min read
Discussing the Big Ideas in Medicine Manufacturing: Part II
January 19, 2026
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
10 min read
First Preclinical Development Candidate for Nucleome Therapeutics
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers
January 15, 2026
About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed
13 min read
Inside 2026: The Industry’s AI Turning Point
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
